Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Takano

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Circulation Journal : Official Journal of the Japanese Circulation Society|June 14, 2013
Effects of pitavastatin in Japanese patients with chronic heart failure. ReplyHiroyuki Takano
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 5, 2018
[Home Medical Care for Heart Failure Patients: Pharmaceutical Education Program of Chiba University]Hiroyuki Takano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[G-CSF therapy for acute myocardial infarction]Hiroyuki Takano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[PPARs and heart diseases]Hiroyuki Takano, Issei Komuro
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 2, 2016
Collaborative Approach to Heart Failure CareHiroyuki Takano, Yukihito Sato
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2004
[Gene therapy and cytokine therapy for acute coronary syndrome]Hiroyuki Takano, Issei Komuro
Journal of Diabetes and Its Complications|March 2, 2002
Roles of peroxisome proliferator-activated receptor gamma in cardiovascular diseaseHiroyuki Takano, Issei Komuro
Circulation Journal : Official Journal of the Japanese Circulation Society|January 9, 2009
Peroxisome proliferator-activated receptor gamma and cardiovascular diseasesHiroyuki Takano, Issei Komuro
Internal Medicine (Tokyo, Japan)|September 5, 2002
Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompactionHiroyuki Takano, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 15, 2008
[Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease]Hiroya Narumi, Hiroyuki Takano, Issei Komuro
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Circulation Journal : Official Journal of the Japanese Circulation Society|June 14, 2013
Effects of pitavastatin in Japanese patients with chronic heart failure. ReplyHiroyuki Takano
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 5, 2018
[Home Medical Care for Heart Failure Patients: Pharmaceutical Education Program of Chiba University]Hiroyuki Takano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[G-CSF therapy for acute myocardial infarction]Hiroyuki Takano
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 15, 2005
[PPARs and heart diseases]Hiroyuki Takano, Issei Komuro
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|August 2, 2016
Collaborative Approach to Heart Failure CareHiroyuki Takano, Yukihito Sato
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|March 11, 2004
[Gene therapy and cytokine therapy for acute coronary syndrome]Hiroyuki Takano, Issei Komuro
Journal of Diabetes and Its Complications|March 2, 2002
Roles of peroxisome proliferator-activated receptor gamma in cardiovascular diseaseHiroyuki Takano, Issei Komuro
Circulation Journal : Official Journal of the Japanese Circulation Society|January 9, 2009
Peroxisome proliferator-activated receptor gamma and cardiovascular diseasesHiroyuki Takano, Issei Komuro
Internal Medicine (Tokyo, Japan)|September 5, 2002
Beta-blockers have beneficial effects even on unclassified cardiomyopathy such as isolated ventricular noncompactionHiroyuki Takano, Issei Komuro
Nihon Rinsho. Japanese Journal of Clinical Medicine|August 15, 2008
[Blood pressure goal and choice of antihypertensive treatment in patients with mild hypertensive cardiovascular disease]Hiroya Narumi, Hiroyuki Takano, Issei Komuro
Pageof 11